Theralink THER Stock
Theralink Price Chart
Theralink THER Financial and Trading Overview
| Theralink stock price | 0.0010 USD |
| Previous Close | 0.0016 USD |
| Open | 0.0019 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0018 - 0.0019 USD |
| 52 Week Range | 0.001 - 0.02 USD |
| Volume | 239.5K USD |
| Avg. Volume | 2.15M USD |
| Market Cap | 11.07M USD |
| Beta (5Y Monthly) | 20.229929 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
THER Valuation Measures
| Enterprise Value | 17.12M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 15.943135 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 24.65 |
| Enterprise Value/EBITDA | -1.295 |
Trading Information
Theralink Stock Price History
| Beta (5Y Monthly) | 20.229929 |
| 52-Week Change | -60.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.001 USD |
| 50-Day Moving Average | 0.00185 USD |
| 200-Day Moving Average | 0.002797 USD |
THER Share Statistics
| Avg. Volume (3 month) | 2.15M USD |
| Avg. Daily Volume (10-Days) | 1.54M USD |
| Shares Outstanding | 6.15B |
| Float | 1.07B |
| Short Ratio | N/A |
| % Held by Insiders | 83.60% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:750 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1932.25% |
| Gross Margin | 56.71% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -332.20% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 694.51K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 770.69% |
| Gross Profit (ttm) | 204.58K USD |
| EBITDA | -13219378 USD |
| Net Income Avi to Common (ttm) | -54576208 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 208.82K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 7.49M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.008 |
| Book Value Per Share (mrq) | -0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6087989 USD |
| Levered Free Cash Flow (ttm) | 46.07M USD |
Profile of Theralink
| Country | United States |
| State | CO |
| City | Golden |
| Address | 15000 West 6th Avenue |
| ZIP | 80401 |
| Phone | 720 420 0074 |
| Website | https://theralink.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.
Q&A For Theralink Stock
What is a current THER stock price?
Theralink THER stock price today per share is 0.0010 USD.
How to purchase Theralink stock?
You can buy THER shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Theralink?
The stock symbol or ticker of Theralink is THER.
Which industry does the Theralink company belong to?
The Theralink industry is Biotechnology.
How many shares does Theralink have in circulation?
The max supply of Theralink shares is 6.15B.
What is Theralink Price to Earnings Ratio (PE Ratio)?
Theralink PE Ratio is now.
What was Theralink earnings per share over the trailing 12 months (TTM)?
Theralink EPS is 0 USD over the trailing 12 months.
Which sector does the Theralink company belong to?
The Theralink sector is Healthcare.